DAVID JONES: Open Payments
NPI 1962824151 · WASHINGTON TERRACE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 105 payments from 27 companies in 2025. Trend: 2023 $2,220 · 2024 $2,448 · 2025 $2,394
Food & beverage: $2,282Education: $111
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $508 |
| EMD Serono, Inc. | 10 | $193 |
| ARGENX US, INC. | 7 | $183 |
| Teva Pharmaceuticals USA, Inc. | 4 | $145 |
| ABBVIE INC. | 6 | $138 |
| Neurocrine BioSciences, Inc. | 7 | $137 |
| Lilly USA, LLC | 7 | $127 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Eisai Inc. | 4 | $91 |
| Janssen Biotech, Inc. | 3 | $81 |
Products named: Rystiggo, VYVGART HYTRULO, INGREZZA, KISUNLA, ZEPOSIA, Briviact, Leqembi, VYEPTI.
Industry payments across UT — which companies pay providers there.
